Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4176438
Max Phase: Preclinical
Molecular Formula: C45H65N7O7
Molecular Weight: 816.06
Molecule Type: Small molecule
Associated Items:
ID: ALA4176438
Max Phase: Preclinical
Molecular Formula: C45H65N7O7
Molecular Weight: 816.06
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)C[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)CCc2ccccc2)CCCCCCC[C@@H](C(=O)N(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O
Standard InChI: InChI=1S/C45H65N7O7/c1-30(2)28-36-41(55)46-31(3)44(58)52-27-17-24-38(52)43(57)49-35(45(59)51(4)5)23-16-8-6-7-15-22-34(40(54)50-36)48-42(56)37(29-33-20-13-10-14-21-33)47-39(53)26-25-32-18-11-9-12-19-32/h9-14,18-21,30-31,34-38H,6-8,15-17,22-29H2,1-5H3,(H,46,55)(H,47,53)(H,48,56)(H,49,57)(H,50,54)/t31-,34-,35-,36-,37-,38-/m0/s1
Standard InChI Key: GSINGDMHIPZAJY-DLXWRWKMSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 816.06 | Molecular Weight (Monoisotopic): 815.4945 | AlogP: 3.18 | #Rotatable Bonds: 11 |
Polar Surface Area: 186.12 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 5 |
#RO5 Violations: 1 | HBA (Lipinski): 14 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 11.86 | CX Basic pKa: | CX LogP: 3.57 | CX LogD: 3.57 |
Aromatic Rings: 2 | Heavy Atoms: 59 | QED Weighted: 0.23 | Np Likeness Score: 0.25 |
1. Chen X, Liu L, Chen Y, Yang Y, Yang CY, Guo T, Lei M, Sun H, Wang S.. (2018) Cyclic Peptidic Mimetics of Apollo Peptides Targeting Telomeric Repeat Binding Factor 2 (TRF2) and Apollo Interaction., 9 (5): [PMID:29795768] [10.1021/acsmedchemlett.8b00152] |
Source(1):